학술논문 – 법학도서관

학술논문

replay검색결과 돌아가기

search검색화면

CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment

Document Type

Article

Author

Swan, D.; Henderson, R.; McEllistrim, C.; Naicker, S.D.; Quinn, J.; Cahill, M.R.; Mykytiv, V.; Lenihan, E.; Mulvaney, E.; Nolan, M.; Parker, I.; Natoni, A.; Lynch, K.; Ryan, A.E.; Szegezdi, E.; Krawczyk, J.; Murphy, P.; O'Dwyer, M.

Source

In Clinical Lymphoma, Myeloma and Leukemia November 2022 22(11):847-852

Subject

Language

ISSN

2152-2650

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Web of Science JCR 저널정보 Find it@PNU

이메일